The Na ϩ ,K ϩ -ATPase, or "sodium pump," is an integral membrane protein that provides an energetic underpinning to salt and nutrient reabsorption in the nephron, as well as being the central modulator of fluid and electrolyte homeostasis in humans. 1,2 The exclusive basolateral localization of the sodium pump in renal (and gastrointestinal) epithelia and its functional coupling to apical sodium-dependent transport systems provide the basis for much of our understanding of renal function. The emergence of this knowledge has been a major achievement of the reductionist approach to physiologic function. The recent demonstration of a physiologic role for the ouabain-binding site in the renal response to salt challenge provides an elegant demonstration of the power of extending knowledge obtained from studies of the structure and function of single proteins to the elucidation of renal function in living organisms.
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The phrase "ouabain (or digitalis) sensitive" has become a synonym for sodium pump-mediated processes, which reflects the exquisite selectivity of cardiac glycosides for this protein. Recently, this pharmacologic shorthand has taken on a fascinating and physiologically significant new dimension. It has been proposed that the highly conserved sensitivity of the sodium pump to these naturally occurring plant products mirrors the actions of endogenous circulating inhibitors of the sodium pump. These inhibitors may have an important physiologic role in pump regulation, influencing salt and water homeostasis, and in the regulation of BP. The article in this issue of JASN by Loreaux et al. 3 provides compelling evidence in support of this hypothesis and points to an important regulatory role of an endogenous sodium pump inhibitor in renal function.
The cloning of the sodium pump proteins in the 1990s led to the discovery of several isoforms of the two major pump subunits and the importance of the ␣ subunit in ouabain sensitivity. 4 Subsequent studies provided a rationale for the welldocumented variation in sensitivity of the pump to cardiac glycosides and the realization that the relative sensitivity of the renal (and housekeeping) sodium pump isoform (␣ 1 ) could be rendered resistant by substituting only two specific amino acid residues. 5 Coupling this molecular physiologic strategy with transgenic mouse models provides persuasive evidence that sodium pump molecules engineered into mice that differ from the native pumps with respect only to their cardiac glycoside sensitivities produce significant and profound physiologic consequences. 6 -8 The study by Loreaux et al. is an extension of recent work, also using this type of transgenic mouse model, that provided compelling evidence that mutation of the ouabain-binding site on the ␣ 2 isoform of the sodium pump, making it go from ouabain sensitive to ouabain resistant, yields mice that are resistant to ACTH-induced hypertension. 9 The interpretation of these observations, that the ouabain-binding site on the sodium pump is responsive to the ACTH-induced release of an endogenous hormone, offers an important link between the sodium pump ouabain-binding site and increased BP. 7, 10 Alterations in the ouabain-binding region of the pump that do not affect its active transport function but modulate relevant ouabain sensitivity instead suggest the pump responds physiologically to the presence of an endogenous ligand at this receptor site.
In the article by Loreaux et al., 3 the authors modified and reversed the ouabain sensitivity of the mouse ␣ 1 and ␣ 2 isoforms to examine the role of the ␣ 1 ouabain-binding site in the renal response to salt challenge. The two major findings are that mice expressing a more ouabain-sensitive sodium pump responded to a sodium load with a greater level of natriuresis than did mice expressing the wild-type isoform, and, strikingly, treatment with cardiac glycoside-sequestering antibodies equalized the natriuretic response in these mice. The most plausible explanation for such observations is that ouabainbinding characteristics of sodium pumps play a role in the regulation of salt and water balance, and the physiologic mechanism occurs through the actions of a circulating effector of the sodium pump that acts through the ouabain-binding site.
More than 20 years ago, de Wardener 11 hypothesized the existence of a natriuretic hormone and its putative involvement in hypertension, and extensive work has been carried out to identify this natriuretic factor. 12 The article by Loreaux et al. advances these studies using a different approach, by showing that the ouabain sensitivity of the ␣ 1 subunit and its manipulation influence renal salt handling and excretion in a way that is abolished by the presence of a reagent (the antidigitalis antibody) that removes circulating digitalis-like substances. There is a great deal of evidence that endogenous circulating cardiotonic steroid levels are higher in patients with some forms of hypertension, 12-14 and it seems clear their actions are exerted through "receptor" sites on tissue sodium pumps.
The question of how cells respond to occupancy of a fraction of their sodium pumps is central to understanding the basis of many physiologic responses in which pump modulation may play a role. There are several different alternatives; these include cellular responses to changes in sodium concentrations, such as consequent changes in calcium concentra-tions that may occur globally or locally, if a subset of sodium pumps are a part of specialized microdomains in such cells, or they may involve the postulated actions of the sodium pump as part of a signaling complex that responds to ouabain occupancy by activating intracellular signaling cascades. 15 It is likely that all three mechanisms occur in a variety of physiologic situations.
It is clear today that the sodium pump, the first protein discovered as an ATP-dependent active ion transporter, whose ion pumping is central to renal function plays a more complex role in the regulation of salt and electrolyte homeostasis than previously recognized. The modulation of its actions by endogenous inhibitors has profound effects on cardiovascular and renal function. Identification of these endogenous modulators will be an exciting next step in better understanding their role in renal physiology.
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